Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures



Status:Completed
Conditions:Neurology, Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:16 - 60
Updated:7/19/2018
Start Date:April 2008
End Date:June 2010

Use our guide to learn which trials are right for you!

A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures

The purpose of this study is to allow eligible subjects from the parent study, SP925
[NCT00655551] to continue lacosamide and to obtain additional long-term safety data

A multicenter, open-label extension study to assess the long-term safety and tolerability of
lacosamide as adjunctive therapy in subjects with partial-onset seizures who were previously
enrolled in the SP925 study [NCT00655551] (intravenous lacosamide loading dose followed by
approximately 1 week of oral lacosamide maintenance).

Inclusion Criteria:

- Eligible subjects who participated in SP925 [NCT00655551] for treatment of
partial-onset seizures

Exclusion Criteria:

- Receiving any study drug or experimental device other than lacosamide

- Meets withdrawal criteria for parent study SP925 [NCT00655551]

- Experiencing ongoing serious adverse event
We found this trial at
7
sites
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
1554
mi
from 91732
Chesterfield, MO
Click here to add this to my saved trials
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials